Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 27, 2026 20:19 UTC |
Nilsson StefanPresident, Nobel Biocare
|
Tax withholdingCommon Stock | 804 | $27.47 | $22,085.88 |
DisclosureSEC source: 0002045818-26-000005 · wk-form4_1787861937.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,560 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:25 UTC |
Acurio VeronicaPresident, Orthodontics
|
Tax withholdingCommon Stock | 7,710 | $27.47 | $211,793.70 |
DisclosureSEC source: 0002045846-26-000007 · wk-form4_1787862328.xml · nonDerivative · entry 1 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,806 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:23 UTC |
Befidi RobertPresident, Diagnostics
|
Tax withholdingCommon Stock | 5,147 | $27.47 | $141,388.09 |
DisclosureSEC source: 0002012361-26-000007 · wk-form4_1787862196.xml · nonDerivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,785 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:21 UTC |
Hammes Eric D.Chief Financial Officer
|
Tax withholdingCommon Stock | 10,885 | $27.47 | $299,010.95 |
DisclosureSEC source: 0001610493-26-000009 · wk-form4_1787862063.xml · nonDerivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,913 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 20:25 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
SaleCommon Stock | 8,000 | $27.50 | $220,000.00 |
DisclosureSEC source: 0001788632-26-000009 · wk-form4_1787603134.xml · nonDerivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,321 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 20:15 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantPerformance Share Unit · Derivative | 47,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001610493-26-000007 · wk-form4_1787256898.xml · derivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,970 Underlying: Common Stock · 47,970 shares Expires not disclosed F1 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved. F1 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved. F1 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 20:15 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantPerformance Share Unit · Derivative | 159,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001626337-26-000010 · wk-form4_1787256919.xml · derivative · entry 2 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,900 Underlying: Common Stock · 159,900 shares Expires not disclosed F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved. F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved. F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 20:15 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantCommon Stock | 179,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001626337-26-000010 · wk-form4_1787256919.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,304 F1 · shares: Consists of Restricted Stock Units ("RSU") that will vest ratably on each anniversary of the date of grant over four years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| May 25, 2026 Filed May 27, 2026 20:17 UTC |
Keel Paul ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 12,811 | $23.43 | $300,161.73 |
DisclosureSEC source: 0001626337-26-000005 · wk-form4_1779913032.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,574 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:37 UTC |
Pierce James AndrewDirector
|
GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001886518-26-000007 · wk-form4_1779395820.xml · nonDerivative · entry 1 Pierce James Andrew · CIK 0001886518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,485 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:37 UTC |
Jain VivekDirector
|
GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-26-000005 · wk-form4_1779395833.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,945 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:37 UTC |
TSINGOS CHRISTINE ADirector
|
GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001278861-26-000008 · wk-form4_1779395841.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,930 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:36 UTC |
Raskas DanielDirector
|
GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001306860-26-000003 · wk-form4_1779395811.xml · nonDerivative · entry 1 Raskas Daniel · CIK 0001306860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,010 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:37 UTC |
GALLAHUE KIERANDirector
|
GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001308428-26-000003 · wk-form4_1779395827.xml · nonDerivative · entry 1 GALLAHUE KIERAN · CIK 0001308428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,010 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:36 UTC |
Huennekens R ScottDirector
|
GrantCommon Stock | 12,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001365493-26-000003 · wk-form4_1779395802.xml · nonDerivative · entry 1 Huennekens R Scott · CIK 0001365493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,105 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:37 UTC |
Carruthers WendyDirector
|
GrantCommon Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001563565-26-000003 · wk-form4_1779395847.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,940 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Nilsson StefanPresident, Nobel Biocare
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,020 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · derivative · entry 4 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,020 Underlying: Common Stock · 18,020 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Nilsson StefanPresident, Nobel Biocare
|
GrantPerformance Share Unit · Derivative | 13,845 | $0.00 | $0.00 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · derivative · entry 3 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,845 Underlying: Common Stock · 13,845 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Nilsson StefanPresident, Nobel Biocare
|
GrantCommon Stock | 7,605 | $0.00 | $0.00 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · nonDerivative · entry 2 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,364 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Nilsson StefanPresident, Nobel Biocare
|
Tax withholdingCommon Stock | 182 | $29.59 | $5,385.38 |
DisclosureSEC source: 0002045818-26-000002 · wk-form4_1772227172.xml · nonDerivative · entry 1 Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,759 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,020 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · derivative · entry 4 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,020 Underlying: Common Stock · 18,020 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantPerformance Share Unit · Derivative | 13,845 | $0.00 | $0.00 |
DisclosureSEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · derivative · entry 3 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,845 Underlying: Common Stock · 13,845 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Acurio VeronicaPresident, Orthodontics
|
GrantCommon Stock | 7,605 | $0.00 | $0.00 |
DisclosureSEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · nonDerivative · entry 2 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,516 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Acurio VeronicaPresident, Orthodontics
|
Tax withholdingCommon Stock | 1,412 | $29.59 | $41,781.08 |
DisclosureSEC source: 0002045846-26-000004 · wk-form4_1772227178.xml · nonDerivative · entry 1 Acurio Veronica · CIK 0002045846 · President, Orthodontics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,911 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Befidi RobertPresident, Diagnostics
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,020 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · derivative · entry 4 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,020 Underlying: Common Stock · 18,020 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Befidi RobertPresident, Diagnostics
|
GrantPerformance Share Unit · Derivative | 13,845 | $0.00 | $0.00 |
DisclosureSEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · derivative · entry 3 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,845 Underlying: Common Stock · 13,845 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Befidi RobertPresident, Diagnostics
|
GrantCommon Stock | 7,605 | $0.00 | $0.00 |
DisclosureSEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · nonDerivative · entry 2 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,932 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Befidi RobertPresident, Diagnostics
|
Tax withholdingCommon Stock | 2,177 | $29.59 | $64,417.43 |
DisclosureSEC source: 0002012361-26-000004 · wk-form4_1772227143.xml · nonDerivative · entry 1 Befidi Robert · CIK 0002012361 · President, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,327 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 16:19 UTC |
Kaabi Faez CChief Accounting Officer
|
GrantCommon Stock | 13,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001993528-26-000003 · wk-form4_1772227153.xml · nonDerivative · entry 2 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,552 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 16:19 UTC |
Kaabi Faez CChief Accounting Officer
|
Tax withholdingCommon Stock | 4,964 | $29.59 | $146,884.76 |
DisclosureSEC source: 0001993528-26-000003 · wk-form4_1772227153.xml · nonDerivative · entry 1 Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,032 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 38,040 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · derivative · entry 4 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,040 Underlying: Common Stock · 38,040 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantPerformance Share Unit · Derivative | 29,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · derivative · entry 3 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,225 Underlying: Common Stock · 29,225 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Hammes Eric D.Chief Financial Officer
|
GrantCommon Stock | 16,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · nonDerivative · entry 2 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,798 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Hammes Eric D.Chief Financial Officer
|
Tax withholdingCommon Stock | 2,045 | $29.59 | $60,511.55 |
DisclosureSEC source: 0001610493-26-000004 · wk-form4_1772227184.xml · nonDerivative · entry 1 Hammes Eric D. · CIK 0001610493 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,743 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 115,320 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · derivative · entry 4 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,320 Underlying: Common Stock · 115,320 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantPerformance Share Unit · Derivative | 132,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · derivative · entry 3 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,885 Underlying: Common Stock · 132,885 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Keel Paul ADirector · Chief Executive Officer
|
GrantCommon Stock | 48,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · nonDerivative · entry 2 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,385 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Keel Paul ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 11,840 | $29.59 | $350,345.60 |
DisclosureSEC source: 0001626337-26-000004 · wk-form4_1772227148.xml · nonDerivative · entry 1 Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,715 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 16:19 UTC |
Nance Mark EGeneral Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 30,040 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · derivative · entry 4 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,040 Underlying: Common Stock · 30,040 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 16:19 UTC |
Nance Mark EGeneral Counsel
|
GrantPerformance Share Unit · Derivative | 23,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · derivative · entry 3 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,070 Underlying: Common Stock · 23,070 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 16:19 UTC |
Nance Mark EGeneral Counsel
|
GrantCommon Stock | 12,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · nonDerivative · entry 2 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,252 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 16:19 UTC |
Nance Mark EGeneral Counsel
|
Tax withholdingCommon Stock | 3,368 | $29.59 | $99,659.12 |
DisclosureSEC source: 0001755882-26-000004 · wk-form4_1772227158.xml · nonDerivative · entry 1 Nance Mark E · CIK 0001755882 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,577 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 14,020 | $0.00 Strike: $29.59 | $0.00 |
DisclosureSEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · derivative · entry 4 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,020 Underlying: Common Stock · 14,020 shares Expires 2036-02-25 F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantPerformance Share Unit · Derivative | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · derivative · entry 3 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,770 Underlying: Common Stock · 10,770 shares Expires not disclosed F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
GrantCommon Stock | 5,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · nonDerivative · entry 2 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,321 F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:19 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Tax withholdingCommon Stock | 2,976 | $29.59 | $88,059.84 |
DisclosureSEC source: 0001788632-26-000006 · wk-form4_1772227166.xml · nonDerivative · entry 1 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,406 F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 22:15 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,634 | $0.00 Strike: $15.97 | $0.00 |
DisclosureSEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · derivative · entry 6 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,634 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation. F4 · derivative.exercise_date: This Option was fully vested as of May 15, 2022. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 22:15 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,041 | $0.00 Strike: $19.04 | $0.00 |
DisclosureSEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · derivative · entry 5 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,041 shares Expires 2028-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation. F3 · derivative.exercise_date: This Option was fully vested as of February 24, 2023. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 22:15 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
SaleCommon Stock | 5,634 | $30.00 | $169,020.00 |
DisclosureSEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 4 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,382 F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 22:15 UTC |
Reis MischaSVP, Strategy & Bus. Dev.
|
Exercise / conversionCommon Stock | 5,634 | $15.97 | $89,974.98 |
DisclosureSEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 3 Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.